JPMorgan Chase raises HCA Healthcare price target to $332 from $327, exceeding Q4 revenue estimates by 11.2%.
JPMorgan Chase & Co. raised its price target for HCA Healthcare (NYSE:HCA) to $332.00 from $327.00, while Royal Bank of Canada increased its price objective to $329.00 from $322.00, and TD Cowen reduced its price objective from $371.00 to $360.00. HCA Healthcare reported earnings of $5.36 EPS, surpassing consensus estimates by $0.35. Quarterly revenue increased 11.2% YoY.
June 03, 2024
3 Articles